Core Insights - The company Yinos has seen a slight increase in stock price by 0.63% on February 9, with a trading volume of 38.98 million yuan [1] - The financing data indicates a net buying of 542,600 yuan on the same day, with a total financing balance of 36.23 million yuan, which is 0.64% of the circulating market value, indicating a low financing level compared to the past year [1] - The company reported a significant decline in revenue and net profit for the first nine months of 2025, with a revenue of 571 million yuan, down 35.33% year-on-year, and a net loss of 14.79 million yuan, a decrease of 111.14% year-on-year [2] Financing and Shareholder Information - As of February 9, the company had a total financing and securities lending balance of 36.23 million yuan, with the financing balance being at a low level compared to the past year [1] - The number of shareholders decreased by 9.97% to 4,849, while the average circulating shares per person increased by 257.28% to 18,703 shares [2] - The company has distributed a total of 45.11 million yuan in dividends since its A-share listing [3] Institutional Holdings - As of September 30, 2025, new institutional shareholders include Huatai-PineBridge Healthcare Mixed Fund and Huaxia Stable Growth Mixed Fund, which are now among the top ten circulating shareholders [3] - Notably, previous major shareholders such as ICBC Medical Healthcare Stock and ICBC Strategic Transformation Stock A have exited the top ten list [3]
益诺思2月9日获融资买入348.47万元，融资余额3623.07万元